Dunn Mervin
Known title: DirectorCIK: 0001298803
Associated companies
Transaction History
| TDG | ▼ Sell | Open Market | 2,020 | $1.2M | 11/16/2022 | View on chart |
| TDG | ▼ Sell | Open Market | 1,758 | $1.1M | 11/16/2022 | View on chart |
| TDG | ▼ Sell | Open Market | 700 | $430K | 11/16/2022 | View on chart |
| TDG | ▲ Buy | Option Exercise | 4,478 | $722K | 11/16/2022 | View on chart |
| TDG | ▲ Buy | Grant | 63 | $37K | 9/23/2022 | View on chart |
| TDG | ▲ Buy | Grant | 58 | $37K | 3/28/2022 | View on chart |
| TDG | ▲ Buy | Grant | 61 | $37K | 9/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
TDG Analyst Notes Highlight Valuation Concerns
Recent analyst commentary suggests TransDigm may be undervalued, with one source estimating a 23% discount to its current price. RBC Capital kept its sector rating but lowered its price target to $1,200, reflecting a more cautious outlook. A Seeking Alpha piece noted that the stock’s price dynamics are drawing more attention than broader AI themes. These observations come as the shares trade near the $1,219 support level.
TDG Analyst Notes Highlight Valuation Concerns. Recent analyst commentary suggests TransDigm may be undervalued, with one source estimating a 23% discount to its current price. RBC Capital kept its sector rating but lowered its price target to $1,200, reflecting a more cautious outlook. A Seeking Alpha piece noted that the stock’s price dynamics are drawing more attention than broader AI themes. These observations come as the shares trade near the $1,219 support level.